Department of Midwifery and Reproductive Health, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Cellular and Molecular Research Center,Department of Anatomy, Birjand University of Medical Sciences, Birjand, Iran.
J Endocrinol Invest. 2019 Jul;42(7):809-813. doi: 10.1007/s40618-018-0986-x. Epub 2018 Nov 21.
Despite the fact that the ghrelin hormone plays pivotal role in the process of weight gain, its correlation with weighing during pregnancy has not been elucidated. Hence, the present study was conducted to evaluate the correlation between plasma ghrelin levels and gestational weight gain in overweight and normal women.
This prospective cohort study was conducted in 27 overweight and 18 normal body mass index (BMI) pregnant women referring to Tehran health care centers. Weight gain during all trimesters of pregnancy was measured and the blood samples were collected at 8-12 (first trimester) and 16-20 weeks (second trimester) of pregnancy. The plasma total ghrelin concentration was measured by ELISA method.
The overweight pregnant women exhibited significantly lower weight gain at the second (p = 0.002), third trimesters (p = 0.005) as well as total weighing during pregnancy (p = 0.001) compared to the normal BMI pregnant women. There was no significant difference in plasma ghrelin levels between the groups from the first to the second trimesters of pregnancy (p > 0.05). Moreover, no correlation was found between ghrelin levels and gestational weight gain in the overweight and normal groups.
Our results indicate that the increased level of serum ghrelin could not be considered as a key mediator for weight gain difference during pregnancy of overweight women.
尽管生长激素释放肽激素在体重增加过程中发挥着关键作用,但它与妊娠期间体重增加的相关性尚未阐明。因此,本研究旨在评估超重和正常体重孕妇血浆生长激素释放肽水平与妊娠体重增加的相关性。
本前瞻性队列研究纳入了 27 名超重和 18 名正常体重指数(BMI)的孕妇,这些孕妇均来自德黑兰医疗保健中心。测量了所有孕期三个阶段的体重增加,并在妊娠 8-12 周(孕早期)和 16-20 周(孕中期)采集血样。采用 ELISA 法测定血浆总生长激素释放肽浓度。
与正常 BMI 的孕妇相比,超重孕妇在孕中期(p=0.002)、孕晚期(p=0.005)以及整个孕期的体重增加(p=0.001)显著较低。两组孕妇从孕早期到孕中期的血浆生长激素释放肽水平无显著差异(p>0.05)。此外,超重和正常组的生长激素释放肽水平与妊娠体重增加之间均无相关性。
我们的研究结果表明,血清生长激素释放肽水平的升高不能被认为是超重孕妇妊娠期间体重增加差异的关键介导因素。